Literature DB >> 31690315

Correction to: Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages.

Jingjie Li1, Lihuan Guan2, Huizhen Zhang2, Yue Gao2, Jiahong Sun2, Xiao Gong3, Dongshun Li2, Pan Chen4, Xiaoyan Liang1, Min Huang2, Huichang Bi5.   

Abstract

The authors regret that the incorrect identification of "omega-3 arachidonic acid" published in the original manuscript [1].

Entities:  

Year:  2019        PMID: 31690315      PMCID: PMC6833161          DOI: 10.1186/s12958-019-0532-5

Source DB:  PubMed          Journal:  Reprod Biol Endocrinol        ISSN: 1477-7827            Impact factor:   5.211


Correction to: Reprod Biol Endocrinol (2018) 16:42 https://doi.org/10.1186/s12958-018-0360-z The authors regret that the incorrect identification of “omega-3 arachidonic acid” published in the original manuscript [1]. This classification is incorrect as arachidonic acid is an omega-6 polyunsaturated fatty acid. From a mechanistic standpoint, this mistake might have significance, as arachidonic acid is hypothesized to play a role in inflammatory processes. We have carefully double-checked our original data and compared the fragmentation spectra and m/z referring to Metlin Database again. We are sure that the metabolite should be arachidonic acid, instead of omega-3 arachidonic acid. Given that this misclassification is made in several places within the article’s abstract and text, a correction is warranted. Accordingly, the name “omega-3 arachidonic acid” mentioned in the following parts should be corrected as “arachidonic acid”: In the results section of Abstract: “The eutopic endometrium metabolomic profile of the endometriosis patients was characterized by a significant increase in the concentration of hypoxanthine, L-arginine, L-tyrosine, leucine, lysine, inosine, omega-3 arachidonic acid, guanosine……”. In the last paragraph of Introduction: “The eutopic endometrium metabolomic profile of endometriosis patients was characterized by a significant increase in the concentration of hypoxanthine, L-arginine, L-tyrosine, leucine, lysine, inosine, omega-3 arachidonic acid, guanosine……”. In the first paragraph of the section with the subheading “Identification of detected metabolites” of Results: “Obviously, levels of hypoxanthine, L-arginine, L-tyrosine, leucine, lysine, inosine, omega-3 arachidonic acid, guanosine…..” In the first paragraph of Discussion: “In this regard, 11 metabolites including hypoxanthine, L-arginine, L-tyrosine, leucine, lysine, inosine, omega-3 arachidonic acid, guanosine……” Figure 2D, “Omega-3 Arachidonic acid In the third row of Figure 3, “omega-3 arachidonic acid In the third graph in the first row of Figure 4, “Omega-3 Arachidonic acid In the 4th row of RPLC mode in Table 2, “Omega-3 Arachidonic acid The authors would like to apologize for any inconvenience caused.
  1 in total

1.  Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages.

Authors:  Jingjie Li; Lihuan Guan; Huizhen Zhang; Yue Gao; Jiahong Sun; Xiao Gong; Dongshun Li; Pan Chen; Xiaoyan Liang; Min Huang; Huichang Bi
Journal:  Reprod Biol Endocrinol       Date:  2018-04-30       Impact factor: 5.211

  1 in total
  2 in total

Review 1.  Metabolomics in Central Sensitivity Syndromes.

Authors:  Joseph S Miller; Luis Rodriguez-Saona; Kevin V Hackshaw
Journal:  Metabolites       Date:  2020-04-24

2.  Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression.

Authors:  Alicja Warowicka; Badr Qasem; Anna Dera-Szymanowska; Maria Wołuń-Cholewa; Patryk Florczak; Nikodem Horst; Marta Napierała; Krzysztof Szymanowski; Łukasz Popenda; Grażyna Bartkowiak; Ewa Florek; Anna Goździcka-Józefiak; Piotr Młynarz
Journal:  Pharmaceutics       Date:  2021-06-23       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.